OBJECTIVE: To review and critically evaluate the extant research literature pertaining to adherence in youth and adults with headache and to provide recommendations for future research. BACKGROUND: This article provides the first systematic review of pediatric headache adherence and updates a previous review of treatment adherence in adults with headache. DESIGN: Systematic review of empirical literature. METHODS: A literature search with no date restriction was conducted using PubMed and PsycINFO electronic databases and bibliographies of relevant articles. RESULTS: Adherence rates in adults with headache range considerably from 25% to 94% across treatment, assessment method, and definition of adherence utilized. Methods to assess adherence included retrospective prescription claims data, paper or electronic diaries, follow-up appointment attendance, written and verbal self-report of general adherence, verbal self-report of adherence over a specific amount of time via in person interview or telephone, validated adherence measures, adherence questionnaires without validation, and counselor ratings of homework. Each methodology and assessment tool demonstrated strengths and weaknesses. No studies have systematically examined medication adherence in children with headache, and the few available studies examining adherence to behavioral treatment have documented adherence rates ranging from 52% to 86%. CONCLUSIONS: Adherence research in adults with headache is growing, but studies demonstrate a number of methodological shortcomings. Adherence research in children with headache, and adherence intervention research in both adults and children, is scant. Future research should use objective measures of adherence, consider over-the-counter medications and medication overuse, examine demographic, psychological, and behavioral correlates of adherence, assess adherence to botulinum toxin type A, and examine the efficacy of adherence interventions in individuals with headache.
OBJECTIVE: To review and critically evaluate the extant research literature pertaining to adherence in youth and adults with headache and to provide recommendations for future research. BACKGROUND: This article provides the first systematic review of pediatric headache adherence and updates a previous review of treatment adherence in adults with headache. DESIGN: Systematic review of empirical literature. METHODS: A literature search with no date restriction was conducted using PubMed and PsycINFO electronic databases and bibliographies of relevant articles. RESULTS: Adherence rates in adults with headache range considerably from 25% to 94% across treatment, assessment method, and definition of adherence utilized. Methods to assess adherence included retrospective prescription claims data, paper or electronic diaries, follow-up appointment attendance, written and verbal self-report of general adherence, verbal self-report of adherence over a specific amount of time via in person interview or telephone, validated adherence measures, adherence questionnaires without validation, and counselor ratings of homework. Each methodology and assessment tool demonstrated strengths and weaknesses. No studies have systematically examined medication adherence in children with headache, and the few available studies examining adherence to behavioral treatment have documented adherence rates ranging from 52% to 86%. CONCLUSIONS: Adherence research in adults with headache is growing, but studies demonstrate a number of methodological shortcomings. Adherence research in children with headache, and adherence intervention research in both adults and children, is scant. Future research should use objective measures of adherence, consider over-the-counter medications and medication overuse, examine demographic, psychological, and behavioral correlates of adherence, assess adherence to botulinum toxin type A, and examine the efficacy of adherence interventions in individuals with headache.
Authors: Kathleen A Foley; Roger Cady; Vincent Martin; James Adelman; Merle Diamond; Christopher F Bell; Jeffrey M Dayno; X Henry Hu Journal: Headache Date: 2005-05 Impact factor: 5.887
Authors: Mia T Minen; Sarah Azarchi; Rachel Sobolev; Amanda Shallcross; Audrey Halpern; Thomas Berk; Naomi M Simon; Scott Powers; Richard B Lipton; Elizabeth Seng Journal: Pain Med Date: 2018-11-01 Impact factor: 3.750
Authors: Mark Obermann; Eva Bock; Nikolay Sabev; Nils Lehmann; Ralph Weber; Marcus Gerwig; Markus Frings; Diana Arweiler-Harbeck; Stephan Lang; Hans-Christoph Diener Journal: J Neurol Date: 2015-06-20 Impact factor: 4.849
Authors: Ashley M Kroon Van Diest; Rachelle R Ramsey; Susmita Kashikar-Zuck; Shalonda Slater; Kevin Hommel; John W Kroner; Susan LeCates; Marielle A Kabbouche; Hope L O'Brien; Joanne Kacperski; Janelle R Allen; James Peugh; Andrew D Hershey; Scott W Powers Journal: Clin J Pain Date: 2017-10 Impact factor: 3.442